CFAST Launches Two New CDISC Therapeutic Area Standards for Influenza and QT Studies

The Clinical Data Interchange Standards Consortium (CDISC), Critical Path Institute (C-Path) and TransCelerate BioPharma Inc. (“TransCelerate”) announced today that version 1.0 of the CDISC Influenza Therapeutic Area User Guide (TAUG) and version 1.0 of the CDISC QT Studies TAUG are now available for implementers on the CDISC website. CDISC standards facilitate clinical research from end-to-end, from protocol and data collection through analysis and reporting, and have been shown to significantly decrease the time and cost of medical research while improving quality.Continue reading

HealthTell Expands Scientific Advisory Board to Advance Innovation in Diagnostics

Continue reading